Literature DB >> 11213288

Discovery of RWJ-54428 (MC-02,479), a new cephalosporin active against resistant gram-positive bacteria.

S J Hecker1, T W Glinka, A Cho, Z J Zhang, M E Price, S Chamberland, D Griffith, V J Lee.   

Abstract

The discovery of RWJ-54428 (MC-02,479), a new cephalosporin displaying promising activity against sensitive and resistant Gram-positive bacteria, is described. Progressive structural modification from the previously reported 3-phenylthiocephem MC-02,331 afforded an overall increase in potency against MRSA while retaining other key properties such as acceptable solubility and serum binding. Evaluation of the in vitro potency and in vivo efficacy of a series of closely related compounds resulted in selection of RWJ-54428 (MC-02,479) for further studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11213288     DOI: 10.7164/antibiotics.53.1272

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.

Authors:  S Chamberland; J Blais; M Hoang; C Dinh; D Cotter; E Bond; C Gannon; C Park; F Malouin; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.

Authors:  David C Griffith; Laurie Harford; Robert Williams; Ving J Lee; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Prodrugs of cephalosporin RWJ-333441 (MC-04,546) with improved aqueous solubility.

Authors:  Scott J Hecker; Trevor Calkins; Mary E Price; Keith Huie; Sharon Chen; Tomasz W Glinka; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.

Authors:  Francois Malouin; Johanne Blais; Suzanne Chamberland; Monica Hoang; Craig Park; Christin Chan; Kristina Mathias; Samia Hakem; Kelly Dupree; Eric Liu; Tien Nguyen; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.